Mauskopf JA, Graham J, Fay-Azhar M, Kinter E. Budget impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple sclerosis. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.